nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevelamer—Anorexia—Gefitinib—lung cancer	0.00623	0.00623	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Crizotinib—lung cancer	0.00622	0.00622	CcSEcCtD
Sevelamer—Fatigue—Crizotinib—lung cancer	0.00621	0.00621	CcSEcCtD
Sevelamer—Constipation—Crizotinib—lung cancer	0.00616	0.00616	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Pemetrexed—lung cancer	0.006	0.006	CcSEcCtD
Sevelamer—Dyspepsia—Pemetrexed—lung cancer	0.00579	0.00579	CcSEcCtD
Sevelamer—Decreased appetite—Pemetrexed—lung cancer	0.00572	0.00572	CcSEcCtD
Sevelamer—Decreased appetite—Gefitinib—lung cancer	0.00568	0.00568	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00568	0.00568	CcSEcCtD
Sevelamer—Fatigue—Pemetrexed—lung cancer	0.00567	0.00567	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Gefitinib—lung cancer	0.00565	0.00565	CcSEcCtD
Sevelamer—Fatigue—Gefitinib—lung cancer	0.00564	0.00564	CcSEcCtD
Sevelamer—Pain—Pemetrexed—lung cancer	0.00563	0.00563	CcSEcCtD
Sevelamer—Constipation—Pemetrexed—lung cancer	0.00563	0.00563	CcSEcCtD
Sevelamer—Pain—Gefitinib—lung cancer	0.00559	0.00559	CcSEcCtD
Sevelamer—Constipation—Gefitinib—lung cancer	0.00559	0.00559	CcSEcCtD
Sevelamer—Gastrointestinal pain—Pemetrexed—lung cancer	0.00538	0.00538	CcSEcCtD
Sevelamer—Gastrointestinal pain—Gefitinib—lung cancer	0.00535	0.00535	CcSEcCtD
Sevelamer—Abdominal pain—Pemetrexed—lung cancer	0.0052	0.0052	CcSEcCtD
Sevelamer—Abdominal pain—Gefitinib—lung cancer	0.00517	0.00517	CcSEcCtD
Sevelamer—Asthenia—Crizotinib—lung cancer	0.00517	0.00517	CcSEcCtD
Sevelamer—Anorexia—Teniposide—lung cancer	0.00508	0.00508	CcSEcCtD
Sevelamer—Abdominal distension—Irinotecan—lung cancer	0.00493	0.00493	CcSEcCtD
Sevelamer—Diarrhoea—Crizotinib—lung cancer	0.00493	0.00493	CcSEcCtD
Sevelamer—Ileus—Doxorubicin—lung cancer	0.00476	0.00476	CcSEcCtD
Sevelamer—Asthenia—Pemetrexed—lung cancer	0.00472	0.00472	CcSEcCtD
Sevelamer—Flatulence—Erlotinib—lung cancer	0.00472	0.00472	CcSEcCtD
Sevelamer—Asthenia—Gefitinib—lung cancer	0.00469	0.00469	CcSEcCtD
Sevelamer—Pruritus—Pemetrexed—lung cancer	0.00466	0.00466	CcSEcCtD
Sevelamer—Decreased appetite—Teniposide—lung cancer	0.00463	0.00463	CcSEcCtD
Sevelamer—Pruritus—Gefitinib—lung cancer	0.00463	0.00463	CcSEcCtD
Sevelamer—Vomiting—Crizotinib—lung cancer	0.00458	0.00458	CcSEcCtD
Sevelamer—Rash—Crizotinib—lung cancer	0.00454	0.00454	CcSEcCtD
Sevelamer—Dermatitis—Crizotinib—lung cancer	0.00454	0.00454	CcSEcCtD
Sevelamer—Diarrhoea—Pemetrexed—lung cancer	0.0045	0.0045	CcSEcCtD
Sevelamer—Diarrhoea—Gefitinib—lung cancer	0.00447	0.00447	CcSEcCtD
Sevelamer—Gastrointestinal pain—Teniposide—lung cancer	0.00436	0.00436	CcSEcCtD
Sevelamer—Nausea—Crizotinib—lung cancer	0.00428	0.00428	CcSEcCtD
Sevelamer—Abdominal pain—Teniposide—lung cancer	0.00421	0.00421	CcSEcCtD
Sevelamer—Vomiting—Pemetrexed—lung cancer	0.00418	0.00418	CcSEcCtD
Sevelamer—Vomiting—Gefitinib—lung cancer	0.00416	0.00416	CcSEcCtD
Sevelamer—Rash—Pemetrexed—lung cancer	0.00415	0.00415	CcSEcCtD
Sevelamer—Dermatitis—Pemetrexed—lung cancer	0.00415	0.00415	CcSEcCtD
Sevelamer—Rash—Gefitinib—lung cancer	0.00412	0.00412	CcSEcCtD
Sevelamer—Arthralgia—Topotecan—lung cancer	0.00412	0.00412	CcSEcCtD
Sevelamer—Dermatitis—Gefitinib—lung cancer	0.00412	0.00412	CcSEcCtD
Sevelamer—Arthralgia—Erlotinib—lung cancer	0.00408	0.00408	CcSEcCtD
Sevelamer—Abdominal distension—Paclitaxel—lung cancer	0.00402	0.00402	CcSEcCtD
Sevelamer—Nausea—Pemetrexed—lung cancer	0.00391	0.00391	CcSEcCtD
Sevelamer—Nausea—Gefitinib—lung cancer	0.00388	0.00388	CcSEcCtD
Sevelamer—Anorexia—Vinblastine—lung cancer	0.00388	0.00388	CcSEcCtD
Sevelamer—Asthenia—Teniposide—lung cancer	0.00382	0.00382	CcSEcCtD
Sevelamer—Pruritus—Teniposide—lung cancer	0.00377	0.00377	CcSEcCtD
Sevelamer—Anorexia—Topotecan—lung cancer	0.00377	0.00377	CcSEcCtD
Sevelamer—Anorexia—Erlotinib—lung cancer	0.00373	0.00373	CcSEcCtD
Sevelamer—Diarrhoea—Teniposide—lung cancer	0.00365	0.00365	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Topotecan—lung cancer	0.0036	0.0036	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00356	0.00356	CcSEcCtD
Sevelamer—Decreased appetite—Vinblastine—lung cancer	0.00354	0.00354	CcSEcCtD
Sevelamer—Arthralgia—Vinorelbine—lung cancer	0.00353	0.00353	CcSEcCtD
Sevelamer—Pain—Vinblastine—lung cancer	0.00348	0.00348	CcSEcCtD
Sevelamer—Constipation—Vinblastine—lung cancer	0.00348	0.00348	CcSEcCtD
Sevelamer—Dyspepsia—Topotecan—lung cancer	0.00348	0.00348	CcSEcCtD
Sevelamer—Dyspepsia—Erlotinib—lung cancer	0.00344	0.00344	CcSEcCtD
Sevelamer—Decreased appetite—Topotecan—lung cancer	0.00343	0.00343	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Topotecan—lung cancer	0.00341	0.00341	CcSEcCtD
Sevelamer—Fatigue—Topotecan—lung cancer	0.00341	0.00341	CcSEcCtD
Sevelamer—Decreased appetite—Erlotinib—lung cancer	0.0034	0.0034	CcSEcCtD
Sevelamer—Vomiting—Teniposide—lung cancer	0.00339	0.00339	CcSEcCtD
Sevelamer—Pain—Topotecan—lung cancer	0.00338	0.00338	CcSEcCtD
Sevelamer—Constipation—Topotecan—lung cancer	0.00338	0.00338	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Erlotinib—lung cancer	0.00338	0.00338	CcSEcCtD
Sevelamer—Fatigue—Erlotinib—lung cancer	0.00337	0.00337	CcSEcCtD
Sevelamer—Flatulence—Irinotecan—lung cancer	0.00337	0.00337	CcSEcCtD
Sevelamer—Rash—Teniposide—lung cancer	0.00336	0.00336	CcSEcCtD
Sevelamer—Dermatitis—Teniposide—lung cancer	0.00336	0.00336	CcSEcCtD
Sevelamer—Constipation—Erlotinib—lung cancer	0.00334	0.00334	CcSEcCtD
Sevelamer—Pain—Erlotinib—lung cancer	0.00334	0.00334	CcSEcCtD
Sevelamer—Gastrointestinal pain—Vinblastine—lung cancer	0.00333	0.00333	CcSEcCtD
Sevelamer—Gastrointestinal pain—Topotecan—lung cancer	0.00323	0.00323	CcSEcCtD
Sevelamer—Anorexia—Vinorelbine—lung cancer	0.00322	0.00322	CcSEcCtD
Sevelamer—Abdominal pain—Vinblastine—lung cancer	0.00322	0.00322	CcSEcCtD
Sevelamer—Gastrointestinal pain—Erlotinib—lung cancer	0.0032	0.0032	CcSEcCtD
Sevelamer—Nausea—Teniposide—lung cancer	0.00317	0.00317	CcSEcCtD
Sevelamer—Abdominal pain—Topotecan—lung cancer	0.00312	0.00312	CcSEcCtD
Sevelamer—Abdominal pain—Erlotinib—lung cancer	0.00309	0.00309	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00308	0.00308	CcSEcCtD
Sevelamer—Flatulence—Cisplatin—lung cancer	0.00306	0.00306	CcSEcCtD
Sevelamer—Decreased appetite—Vinorelbine—lung cancer	0.00294	0.00294	CcSEcCtD
Sevelamer—Asthenia—Vinblastine—lung cancer	0.00292	0.00292	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00292	0.00292	CcSEcCtD
Sevelamer—Fatigue—Vinorelbine—lung cancer	0.00291	0.00291	CcSEcCtD
Sevelamer—Constipation—Vinorelbine—lung cancer	0.00289	0.00289	CcSEcCtD
Sevelamer—Pain—Vinorelbine—lung cancer	0.00289	0.00289	CcSEcCtD
Sevelamer—Asthenia—Topotecan—lung cancer	0.00283	0.00283	CcSEcCtD
Sevelamer—Arthralgia—Gemcitabine—lung cancer	0.00283	0.00283	CcSEcCtD
Sevelamer—Asthenia—Erlotinib—lung cancer	0.0028	0.0028	CcSEcCtD
Sevelamer—Pruritus—Topotecan—lung cancer	0.0028	0.0028	CcSEcCtD
Sevelamer—Diarrhoea—Vinblastine—lung cancer	0.00278	0.00278	CcSEcCtD
Sevelamer—Pruritus—Erlotinib—lung cancer	0.00277	0.00277	CcSEcCtD
Sevelamer—Gastrointestinal pain—Vinorelbine—lung cancer	0.00276	0.00276	CcSEcCtD
Sevelamer—Flatulence—Paclitaxel—lung cancer	0.00274	0.00274	CcSEcCtD
Sevelamer—Diarrhoea—Topotecan—lung cancer	0.0027	0.0027	CcSEcCtD
Sevelamer—Diarrhoea—Erlotinib—lung cancer	0.00267	0.00267	CcSEcCtD
Sevelamer—Abdominal pain—Vinorelbine—lung cancer	0.00267	0.00267	CcSEcCtD
Sevelamer—Anorexia—Irinotecan—lung cancer	0.00266	0.00266	CcSEcCtD
Sevelamer—Anorexia—Gemcitabine—lung cancer	0.00259	0.00259	CcSEcCtD
Sevelamer—Vomiting—Vinblastine—lung cancer	0.00259	0.00259	CcSEcCtD
Sevelamer—Vomiting—Topotecan—lung cancer	0.00251	0.00251	CcSEcCtD
Sevelamer—Rash—Topotecan—lung cancer	0.00249	0.00249	CcSEcCtD
Sevelamer—Dermatitis—Topotecan—lung cancer	0.00249	0.00249	CcSEcCtD
Sevelamer—Vomiting—Erlotinib—lung cancer	0.00249	0.00249	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00247	0.00247	CcSEcCtD
Sevelamer—Rash—Erlotinib—lung cancer	0.00246	0.00246	CcSEcCtD
Sevelamer—Dermatitis—Erlotinib—lung cancer	0.00246	0.00246	CcSEcCtD
Sevelamer—Dyspepsia—Irinotecan—lung cancer	0.00245	0.00245	CcSEcCtD
Sevelamer—Asthenia—Vinorelbine—lung cancer	0.00243	0.00243	CcSEcCtD
Sevelamer—Decreased appetite—Irinotecan—lung cancer	0.00242	0.00242	CcSEcCtD
Sevelamer—Nausea—Vinblastine—lung cancer	0.00242	0.00242	CcSEcCtD
Sevelamer—Anorexia—Cisplatin—lung cancer	0.00241	0.00241	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Irinotecan—lung cancer	0.00241	0.00241	CcSEcCtD
Sevelamer—Fatigue—Irinotecan—lung cancer	0.0024	0.0024	CcSEcCtD
Sevelamer—Pruritus—Vinorelbine—lung cancer	0.00239	0.00239	CcSEcCtD
Sevelamer—Pain—Irinotecan—lung cancer	0.00238	0.00238	CcSEcCtD
Sevelamer—Constipation—Irinotecan—lung cancer	0.00238	0.00238	CcSEcCtD
Sevelamer—Arthralgia—Paclitaxel—lung cancer	0.00237	0.00237	CcSEcCtD
Sevelamer—Decreased appetite—Gemcitabine—lung cancer	0.00236	0.00236	CcSEcCtD
Sevelamer—Nausea—Topotecan—lung cancer	0.00235	0.00235	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00234	0.00234	CcSEcCtD
Sevelamer—Fatigue—Gemcitabine—lung cancer	0.00234	0.00234	CcSEcCtD
Sevelamer—Pain—Gemcitabine—lung cancer	0.00232	0.00232	CcSEcCtD
Sevelamer—Constipation—Gemcitabine—lung cancer	0.00232	0.00232	CcSEcCtD
Sevelamer—Nausea—Erlotinib—lung cancer	0.00232	0.00232	CcSEcCtD
Sevelamer—Diarrhoea—Vinorelbine—lung cancer	0.00231	0.00231	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00231	0.00231	CcSEcCtD
Sevelamer—Gastrointestinal pain—Irinotecan—lung cancer	0.00228	0.00228	CcSEcCtD
Sevelamer—Anorexia—Etoposide—lung cancer	0.00221	0.00221	CcSEcCtD
Sevelamer—Abdominal pain—Irinotecan—lung cancer	0.0022	0.0022	CcSEcCtD
Sevelamer—Decreased appetite—Cisplatin—lung cancer	0.0022	0.0022	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Cisplatin—lung cancer	0.00219	0.00219	CcSEcCtD
Sevelamer—Anorexia—Paclitaxel—lung cancer	0.00217	0.00217	CcSEcCtD
Sevelamer—Pain—Cisplatin—lung cancer	0.00216	0.00216	CcSEcCtD
Sevelamer—Vomiting—Vinorelbine—lung cancer	0.00215	0.00215	CcSEcCtD
Sevelamer—Rash—Vinorelbine—lung cancer	0.00213	0.00213	CcSEcCtD
Sevelamer—Dermatitis—Vinorelbine—lung cancer	0.00213	0.00213	CcSEcCtD
Sevelamer—Abdominal distension—Doxorubicin—lung cancer	0.00213	0.00213	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00207	0.00207	CcSEcCtD
Sevelamer—Decreased appetite—Etoposide—lung cancer	0.00202	0.00202	CcSEcCtD
Sevelamer—Arthralgia—Docetaxel—lung cancer	0.00201	0.00201	CcSEcCtD
Sevelamer—Nausea—Vinorelbine—lung cancer	0.00201	0.00201	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Etoposide—lung cancer	0.002	0.002	CcSEcCtD
Sevelamer—Dyspepsia—Paclitaxel—lung cancer	0.002	0.002	CcSEcCtD
Sevelamer—Asthenia—Irinotecan—lung cancer	0.002	0.002	CcSEcCtD
Sevelamer—Fatigue—Etoposide—lung cancer	0.002	0.002	CcSEcCtD
Sevelamer—Pain—Etoposide—lung cancer	0.00198	0.00198	CcSEcCtD
Sevelamer—Constipation—Etoposide—lung cancer	0.00198	0.00198	CcSEcCtD
Sevelamer—Decreased appetite—Paclitaxel—lung cancer	0.00198	0.00198	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00196	0.00196	CcSEcCtD
Sevelamer—Fatigue—Paclitaxel—lung cancer	0.00196	0.00196	CcSEcCtD
Sevelamer—Asthenia—Gemcitabine—lung cancer	0.00195	0.00195	CcSEcCtD
Sevelamer—Pain—Paclitaxel—lung cancer	0.00194	0.00194	CcSEcCtD
Sevelamer—Constipation—Paclitaxel—lung cancer	0.00194	0.00194	CcSEcCtD
Sevelamer—Pruritus—Gemcitabine—lung cancer	0.00192	0.00192	CcSEcCtD
Sevelamer—Diarrhoea—Irinotecan—lung cancer	0.00191	0.00191	CcSEcCtD
Sevelamer—Gastrointestinal pain—Etoposide—lung cancer	0.0019	0.0019	CcSEcCtD
Sevelamer—Gastrointestinal pain—Paclitaxel—lung cancer	0.00186	0.00186	CcSEcCtD
Sevelamer—Diarrhoea—Gemcitabine—lung cancer	0.00186	0.00186	CcSEcCtD
Sevelamer—Anorexia—Docetaxel—lung cancer	0.00184	0.00184	CcSEcCtD
Sevelamer—Abdominal pain—Etoposide—lung cancer	0.00183	0.00183	CcSEcCtD
Sevelamer—Asthenia—Cisplatin—lung cancer	0.00182	0.00182	CcSEcCtD
Sevelamer—Abdominal pain—Paclitaxel—lung cancer	0.0018	0.0018	CcSEcCtD
Sevelamer—Vomiting—Irinotecan—lung cancer	0.00177	0.00177	CcSEcCtD
Sevelamer—Rash—Irinotecan—lung cancer	0.00176	0.00176	CcSEcCtD
Sevelamer—Dermatitis—Irinotecan—lung cancer	0.00176	0.00176	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Docetaxel—lung cancer	0.00176	0.00176	CcSEcCtD
Sevelamer—Diarrhoea—Cisplatin—lung cancer	0.00173	0.00173	CcSEcCtD
Sevelamer—Vomiting—Gemcitabine—lung cancer	0.00173	0.00173	CcSEcCtD
Sevelamer—Rash—Gemcitabine—lung cancer	0.00171	0.00171	CcSEcCtD
Sevelamer—Dermatitis—Gemcitabine—lung cancer	0.00171	0.00171	CcSEcCtD
Sevelamer—Dyspepsia—Docetaxel—lung cancer	0.0017	0.0017	CcSEcCtD
Sevelamer—Decreased appetite—Docetaxel—lung cancer	0.00168	0.00168	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Docetaxel—lung cancer	0.00166	0.00166	CcSEcCtD
Sevelamer—Asthenia—Etoposide—lung cancer	0.00166	0.00166	CcSEcCtD
Sevelamer—Fatigue—Docetaxel—lung cancer	0.00166	0.00166	CcSEcCtD
Sevelamer—Nausea—Irinotecan—lung cancer	0.00166	0.00166	CcSEcCtD
Sevelamer—Constipation—Docetaxel—lung cancer	0.00165	0.00165	CcSEcCtD
Sevelamer—Pain—Docetaxel—lung cancer	0.00165	0.00165	CcSEcCtD
Sevelamer—Pruritus—Etoposide—lung cancer	0.00164	0.00164	CcSEcCtD
Sevelamer—Asthenia—Paclitaxel—lung cancer	0.00163	0.00163	CcSEcCtD
Sevelamer—Nausea—Gemcitabine—lung cancer	0.00161	0.00161	CcSEcCtD
Sevelamer—Vomiting—Cisplatin—lung cancer	0.00161	0.00161	CcSEcCtD
Sevelamer—Pruritus—Paclitaxel—lung cancer	0.00161	0.00161	CcSEcCtD
Sevelamer—Rash—Cisplatin—lung cancer	0.0016	0.0016	CcSEcCtD
Sevelamer—Dermatitis—Cisplatin—lung cancer	0.00159	0.00159	CcSEcCtD
Sevelamer—Diarrhoea—Etoposide—lung cancer	0.00159	0.00159	CcSEcCtD
Sevelamer—Gastrointestinal pain—Docetaxel—lung cancer	0.00158	0.00158	CcSEcCtD
Sevelamer—Diarrhoea—Paclitaxel—lung cancer	0.00156	0.00156	CcSEcCtD
Sevelamer—Abdominal pain—Docetaxel—lung cancer	0.00152	0.00152	CcSEcCtD
Sevelamer—Nausea—Cisplatin—lung cancer	0.0015	0.0015	CcSEcCtD
Sevelamer—Vomiting—Etoposide—lung cancer	0.00147	0.00147	CcSEcCtD
Sevelamer—Rash—Etoposide—lung cancer	0.00146	0.00146	CcSEcCtD
Sevelamer—Dermatitis—Etoposide—lung cancer	0.00146	0.00146	CcSEcCtD
Sevelamer—Flatulence—Doxorubicin—lung cancer	0.00145	0.00145	CcSEcCtD
Sevelamer—Arthralgia—Methotrexate—lung cancer	0.00145	0.00145	CcSEcCtD
Sevelamer—Vomiting—Paclitaxel—lung cancer	0.00145	0.00145	CcSEcCtD
Sevelamer—Rash—Paclitaxel—lung cancer	0.00143	0.00143	CcSEcCtD
Sevelamer—Dermatitis—Paclitaxel—lung cancer	0.00143	0.00143	CcSEcCtD
Sevelamer—Asthenia—Docetaxel—lung cancer	0.00138	0.00138	CcSEcCtD
Sevelamer—Nausea—Etoposide—lung cancer	0.00138	0.00138	CcSEcCtD
Sevelamer—Pruritus—Docetaxel—lung cancer	0.00136	0.00136	CcSEcCtD
Sevelamer—Nausea—Paclitaxel—lung cancer	0.00135	0.00135	CcSEcCtD
Sevelamer—Anorexia—Methotrexate—lung cancer	0.00132	0.00132	CcSEcCtD
Sevelamer—Diarrhoea—Docetaxel—lung cancer	0.00132	0.00132	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00127	0.00127	CcSEcCtD
Sevelamer—Arthralgia—Doxorubicin—lung cancer	0.00125	0.00125	CcSEcCtD
Sevelamer—Vomiting—Docetaxel—lung cancer	0.00123	0.00123	CcSEcCtD
Sevelamer—Dyspepsia—Methotrexate—lung cancer	0.00122	0.00122	CcSEcCtD
Sevelamer—Rash—Docetaxel—lung cancer	0.00122	0.00122	CcSEcCtD
Sevelamer—Dermatitis—Docetaxel—lung cancer	0.00121	0.00121	CcSEcCtD
Sevelamer—Decreased appetite—Methotrexate—lung cancer	0.00121	0.00121	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Methotrexate—lung cancer	0.0012	0.0012	CcSEcCtD
Sevelamer—Fatigue—Methotrexate—lung cancer	0.0012	0.0012	CcSEcCtD
Sevelamer—Pain—Methotrexate—lung cancer	0.00119	0.00119	CcSEcCtD
Sevelamer—Anorexia—Doxorubicin—lung cancer	0.00115	0.00115	CcSEcCtD
Sevelamer—Nausea—Docetaxel—lung cancer	0.00114	0.00114	CcSEcCtD
Sevelamer—Gastrointestinal pain—Methotrexate—lung cancer	0.00114	0.00114	CcSEcCtD
Sevelamer—Abdominal pain—Methotrexate—lung cancer	0.0011	0.0011	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.0011	0.0011	CcSEcCtD
Sevelamer—Dyspepsia—Doxorubicin—lung cancer	0.00106	0.00106	CcSEcCtD
Sevelamer—Decreased appetite—Doxorubicin—lung cancer	0.00105	0.00105	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Doxorubicin—lung cancer	0.00104	0.00104	CcSEcCtD
Sevelamer—Fatigue—Doxorubicin—lung cancer	0.00104	0.00104	CcSEcCtD
Sevelamer—Constipation—Doxorubicin—lung cancer	0.00103	0.00103	CcSEcCtD
Sevelamer—Pain—Doxorubicin—lung cancer	0.00103	0.00103	CcSEcCtD
Sevelamer—Asthenia—Methotrexate—lung cancer	0.000996	0.000996	CcSEcCtD
Sevelamer—Gastrointestinal pain—Doxorubicin—lung cancer	0.000983	0.000983	CcSEcCtD
Sevelamer—Pruritus—Methotrexate—lung cancer	0.000983	0.000983	CcSEcCtD
Sevelamer—Abdominal pain—Doxorubicin—lung cancer	0.000951	0.000951	CcSEcCtD
Sevelamer—Diarrhoea—Methotrexate—lung cancer	0.00095	0.00095	CcSEcCtD
Sevelamer—Vomiting—Methotrexate—lung cancer	0.000883	0.000883	CcSEcCtD
Sevelamer—Rash—Methotrexate—lung cancer	0.000876	0.000876	CcSEcCtD
Sevelamer—Dermatitis—Methotrexate—lung cancer	0.000875	0.000875	CcSEcCtD
Sevelamer—Asthenia—Doxorubicin—lung cancer	0.000863	0.000863	CcSEcCtD
Sevelamer—Pruritus—Doxorubicin—lung cancer	0.000851	0.000851	CcSEcCtD
Sevelamer—Nausea—Methotrexate—lung cancer	0.000825	0.000825	CcSEcCtD
Sevelamer—Diarrhoea—Doxorubicin—lung cancer	0.000823	0.000823	CcSEcCtD
Sevelamer—Vomiting—Doxorubicin—lung cancer	0.000765	0.000765	CcSEcCtD
Sevelamer—Rash—Doxorubicin—lung cancer	0.000758	0.000758	CcSEcCtD
Sevelamer—Dermatitis—Doxorubicin—lung cancer	0.000758	0.000758	CcSEcCtD
Sevelamer—Nausea—Doxorubicin—lung cancer	0.000714	0.000714	CcSEcCtD
